Yuh-Chin Tony Huang

Professor of Medicine

Medicine, Pulmonary, Allergy, and Critical Care Medicine

huang002@mc.duke.edu

Duke Box 3810, Durham, NC 27710

1821 Hillandale Road, Suite 2, Durham, NC 27705

More About This Person

At a Glance

Credentials
1. Education

Academic Experience

Expertise
1. Keywords

Research
1. Selected Grants

Publications
1. Selected Publications

Artistic Works / Events

Teaching
1. Teaching Overview

Advising & Mentoring
1. Available to Mentor

Recognition

Professional Activities

Selected Grants

Tyvaso COPD PII - Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia"

Clinical TrialPrincipal Investigator · Awarded by United Therapeutics Corporation · 2025 - 2030

PILLAR CLI-06001AA1-05 Chiesi

Clinical TrialPrincipal Investigator · Awarded by Chiesi Farmaceutici S.p.A. · 2025 - 2029

TRITON A phase III, 52-week, multinational, multicenter, randomized, double-blind, 2-arm parallel group study comparing efficacy, safety and tolerability of the fixed dose triple combination of beclomethasone dipropionate plus formoterol fumarate

Clinical TrialPrincipal Investigator · Awarded by Chiesi Farmaceutici S.p.A. · 2024 - 2028

A Randomized Phase II Clinical Trial of L-Citrulline to Improve Asthma Control in Obese Late Onset Asthma

Clinical TrialCo Investigator · Awarded by University of Colorado - Denver · 2019 - 2026

ARNASA Study -A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Clinical TrialPrincipal Investigator · Awarded by Genentech, Inc. · 2024 - 2024

GE42063 Xe MRI Assessment of disease progression in patients with COPD w/standard of care medications with or without daily open label Azithromycin treatment to prevent acute exacerbation

Clinical TrialPrincipal Investigator · Awarded by Genentech, Inc. · 2021 - 2024

02-CL-2001a A Multicenter single treatment study to assess the safety and tolerability of lyophilized lucinactant in adults with COVID19 associated acute lung injury

Clinical TrialPrincipal Investigator · Awarded by Windtree Therapeutics, Inc · 2021 - 2023

Mechanisms that Direct Airway Remodeling in Obese Asthma

ResearchInvestigator · Awarded by National Institutes of Health · 2017 - 2023

Interdisciplinary Training Program in Lung Disease

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2009 - 2021

Effects of glycopryrrolate/formoterol (Bevespi) on ventilation and gas exchange abnormalities in COPD assessed by 129Xe MRI

Clinical TrialPrincipal Investigator · Awarded by AstraZeneca Pharmaceuticals, LP · 2018 - 2020

LOTT Option 1

Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2006 - 2016

Long-term Oxygen Treatment Trial (LOTT) - Regional Clinical Centers (RCCs)

ResearchCo Investigator · Awarded by National Institutes of Health · 2006 - 2012

Quotation for review of asthma clinic database records

ResearchPrincipal Investigator · Awarded by Environmental Protection Agency · 2007 - 2009

Acute Lung Injury Mechanisms And Therapy

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1984 - 1999

Acute Lung Injury - Mechanisms And Therapy

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1984 - 1997

Acute Lung Injury And Repair

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1993 - 1995